论文部分内容阅读
目的:观察醒脑静注射液辅助治疗小儿热性惊厥的临床疗效。方法:将70例患儿随机分为2组各35例,对照组给予常规治疗方案,观察组在对照组基础上给予醒脑静注射液,比较2组的临床疗效、体温恢复正常时间、意识恢复时间、血清炎症因子水平以及不良反应。结果:总有效率观察组为88.57%,对照组为68.57%,2组比较,差异有统计学意义(P<0.05)。观察组患儿体温恢复正常时间以及意识恢复时间均低于对照组(P<0.05)。治疗后2组患儿血清炎症因子水平均较治疗前降低(P<0.05),观察组血清炎症因子水平低于对照组(P<0.05)。结论 :醒脑静注射液辅助治疗小儿热性惊厥能够提高临床疗效、缩短患儿病程,有效降低炎症因子水平,值得临床推广运用。
Objective: To observe the clinical effect of Xingnaojing injection in the treatment of pediatric febrile seizures. Methods: Seventy patients were randomly divided into two groups of 35 patients. The control group was given routine treatment. The observation group was given Xingnaojing injection on the basis of the control group. The clinical efficacy, body temperature returned to normal time, consciousness Recovery time, serum levels of inflammatory cytokines and adverse reactions. Results: The total effective rate was 88.57% in the observation group and 68.57% in the control group. There was significant difference between the two groups (P <0.05). The body temperature recovery time and consciousness recovery time in the observation group were lower than those in the control group (P <0.05). Serum levels of inflammatory cytokines in both groups were significantly lower than those before treatment (P <0.05), serum inflammatory factors in the observation group were lower than those in the control group (P <0.05). Conclusion: Xingnaojing injection adjuvant treatment of children with febrile seizures can improve clinical efficacy, shorten the duration of children, effectively reduce the level of inflammatory cytokines, worthy of clinical promotion and use.